Publisher: DelveInsight
Category: Prescription Drugs

Prescription Drugs market research reports by DelveInsight

(641 reports matching your criteria)
    • STELARA Market Drug Insight and Market Forecast − 2032

      STELARA Market Drug Insight and Market Forecast − 2032 “STELARA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about STELARA for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the STELARA for ulcerative colitis in the 7MM, i.e., the ... Read More

    • XELJANZ Market Drug Insight and Market Forecast − 2032

      XELJANZ Market Drug Insight and Market Forecast − 2032 “XELJANZ Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about XELJANZ for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the XELJANZ for ulcerative colitis in the 7MM, i.e., the ... Read More

    • ZEPOSIA Market Drug Insight and Market Forecast − 2032

      ZEPOSIA Market Drug Insight and Market Forecast − 2032 “ZEPOSIA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ZEPOSIA for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the ZEPOSIA for ulcerative colitis in the 7MM, i.e., the ... Read More

    • LUCENTIS Market Drug Insight and Market Forecast − 2032

      LUCENTIS Market Drug Insight and Market Forecast − 2032 “LUCENTIS Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LUCENTIS for Diabetic Retinopathy in the seven major markets. A detailed picture of the LUCENTIS for diabetic retinopathy in the 7MM, i.e., t ... Read More

    • Olaparib ± bevacizumab Emerging Drug Insight and Market Forecast – 2032

      Olaparib ± bevacizumab Emerging Drug Insight and Market Forecast – 2032 “Olaparib ± bevacizumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Olaparib ± bevacizumab for Metastatic Colorectal Cancer in the 7MM. A detailed picture of the Olaparib ± beva ... Read More

    • B244 Emerging Drug Insight and Market Forecast − 2032

      B244 Emerging Drug Insight and Market Forecast − 2032 “B244 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about B244 for Atopic Dermatitis (AD) in the seven major markets. A detailed picture of the B244 for atopic dermatitis in the 7MM, i.e., United States, ... Read More

    • ANJESO Drug Insight and Market Forecast – 2032

      ANJESO Drug Insight and Market Forecast – 2032 “ANJESO Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ANJESO for Postoperative Pain in the United States. A detailed picture of the ANJESO for Postoperative Pain in the United States for the study period 2019–2032 ... Read More

    • AFINITOR Drug Insight and Market Forecast – 2032

      AFINITOR Drug Insight and Market Forecast – 2032 “AFINITOR Drug Insight and Market Forecast – 2032” report provides comprehensive insights about AFINITOR for ER +ve HER2-ve Breast Cancer in the United States. A detailed picture of the AFINITOR for ER+ve HER2-ve Breast Cancer in the United States for ... Read More

    • Opdualag (nivolumab and relatlimab) Drug Insight and Market Forecast – 2035

      Opdualag (nivolumab and relatlimab) Drug Insight and Market Forecast – 2035 “Opdualag (nivolumab and relatlimab) Drug Insight and Market Forecast – 2035” report provides comprehensive insights about Opdualag (nivolumab and relatlimab) for LAG-3 Next-generation Immunotherapies in the 7MM. A detailed ... Read More

    • OPZELURA Market Drug Insight and Market Forecast − 2032

      OPZELURA Market Drug Insight and Market Forecast − 2032 “OPZELURA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about OPZELURA for Atopic Dermatitis (AD) in the seven major markets. A detailed picture of the OPZELURA for atopic dermatitis in the 7MM, i.e., Un ... Read More

    • Elinzanetant Emerging Drug Insight and Market Forecast − 2032

      Elinzanetant Emerging Drug Insight and Market Forecast − 2032 “Elinzanetant Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about elinzanetant for Vasomotor Symptoms in the seven major markets. A detailed picture of the elinzanetant for vasomotor symptoms in ... Read More

    • LYBALVI Market Drug Insight and Market Forecast – 2032

      LYBALVI Market Drug Insight and Market Forecast – 2032 “LYBALVI Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LYBALVI for Bipolar Depression (BD) in the seven major markets. A detailed picture of the LYBALVI for Bipolar Depression in the 7MM, i.e., the ... Read More

    • LATUDA Market Drug Insight and Market Forecast – 2032

      LATUDA Market Drug Insight and Market Forecast – 2032 “LATUDA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LATUDA for Bipolar Depression (BD) in the United States, and Japan. A detailed picture of the LATUDA for Bipolar Depression in the United States, ... Read More

    • PH94B Emerging Drug Insight and Market Forecast – 2032

      PH94B Emerging Drug Insight and Market Forecast – 2032 “PH94B Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about PH94B for Generalized Anxiety Disorder (GAD) in the seven major markets. A detailed picture of the PH94B for Generalized Anxiety Disorder in th ... Read More

    • POSIMIR Drug Insight and Market Forecast – 2032

      POSIMIR Drug Insight and Market Forecast – 2032 “POSIMIR Drug Insight and Market Forecast – 2032” report provides comprehensive insights about POSIMIR for Postoperative Pain in the United States. A detailed picture of the POSIMIR for Postoperative Pain in the United States for the study period 2019– ... Read More

    • SKYRIZI Emerging Drug Insight and Market Forecast − 2032

      SKYRIZI Emerging Drug Insight and Market Forecast − 2032 “SKYRIZI Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SKYRIZI for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the SKYRIZI for ulcerative colitis in the 7MM, i.e., ... Read More

    • AJM300 Market Drug Insight and Market Forecast − 2032

      AJM300 Market Drug Insight and Market Forecast − 2032 “AJM300 Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about AJM300 for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the AJM300 for ulcerative colitis in the 7MM, i.e., the Unit ... Read More

    • Difamilast Market Drug Insight and Market Forecast − 2032

      Difamilast Market Drug Insight and Market Forecast − 2032 “Difamilast Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about difamilast for Atopic Dermatitis (AD) in the seven major markets. A detailed picture of the difamilast for atopic dermatitis in the 7MM, ... Read More

    • Fianlimab (REGN3767) Emerging Drug Insight and Market Forecast – 2035

      Fianlimab (REGN3767) Emerging Drug Insight and Market Forecast – 2035 “Fianlimab (REGN3767) Emerging Drug Insight and Market Forecast – 2035” report provides comprehensive insights about Fianlimab (REGN3767) for LAG-3 Next-generation Immunotherapies in the 7MM. A detailed picture of the Fianlimab (R ... Read More

    • Fezolinetant Emerging Drug Insight and Market Forecast − 2032

      Fezolinetant Emerging Drug Insight and Market Forecast − 2032 “Fezolinetant Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about fezolinetant for Vasomotor Symptoms in the seven major markets. A detailed picture of the fezolinetant for vasomotor symptoms in ... Read More

    • XARACOLL Drug Insight and Market Forecast – 2032

      XARACOLL Drug Insight and Market Forecast – 2032 “XARACOLL Drug Insight and Market Forecast – 2032” report provides comprehensive insights about XARACOLL for Postoperative Pain in the United States. A detailed picture of the XARACOLL for Postoperative Pain in the United States for the study period 2 ... Read More

    • ENTYVIO Market Drug Insight and Market Forecast − 2032

      ENTYVIO Market Drug Insight and Market Forecast − 2032 “ENTYVIO Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ENTYVIO for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the ENTYVIO for ulcerative colitis in the 7MM, i.e., the ... Read More

    • Lomitapide Emerging Drug Insight and Market Forecast − 2032

      Lomitapide Emerging Drug Insight and Market Forecast − 2032 “Lomitapide Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about lomitapide for Severe Hypertriglyceridemia (SHTG) in the six major markets. A detailed picture of the lomitapide for severe hypertrig ... Read More

    • Camizestrant Emerging Drug Insight and Market Forecast – 2032

      Camizestrant Emerging Drug Insight and Market Forecast – 2032 “Camizestrant Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Camizestrant for ER +ve HER2-ve Breast Cancer in the United States. A detailed picture of the Camizestrant for ER+ve HER2-ve Brea ... Read More

    • Nemolizumab Market Drug Insight and Market Forecast − 2032

      Nemolizumab Market Drug Insight and Market Forecast − 2032 “Nemolizumab Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about nemolizumab for Atopic Dermatitis (AD) in the seven major markets. A detailed picture of the nemolizumab for atopic dermatitis in the 7 ... Read More

2 3 4 5 6 7 8 9 10 11

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings